SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.
Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...
News Medical on MSN3d
Bariatric surgery favorably influences progression of cirrhosis, study suggestsA Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...
A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications ...
Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study repor ...
Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...
A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...
Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback